A Phase 2 Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2.0 in Patients with DIPG

Stopped The study is suspended due to lack of funding but not due to safety concerns.

Conditions

• Diffuse Intrinsic Pontine Glioma
• Diffuse Midline Glioma

Interventions

• COMBINATION_PRODUCT: SONALA-001 (ALA) and MR-Guided Focused Ultrasound device (MRgFUS)

Sponsor

SonALAsense, Inc.